Correlation between Serum IL-35 Levels and Bone Loss in Postmenopausal Women with Rheumatoid Arthritis

Figure 1

(a) Serum IL-35 levels in patients with RA and HCs. (b) Serum IL-35 levels in RA patients with normal BMD, osteopenia, and osteoporosis. (c–g) Correlation between serum IL-35 levels and BMD at L1-L4, BMD at total hip, β-CTX, ALP, and 25-(OH) VitD₃. Abbreviations: IL: interleukin; RA: rheumatoid arthritis; HCs: healthy controls; BMD at L1-L4: bone mineral density at lumbar spine 1-4; β-CTX: β-isomerised carboxy-terminal cross-linking telopeptide of type I collagen; ALP: alkaline phosphatase.

(a)

(b)

(c)

(d)

(e)

(f)

(g)